{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:38:04Z","timestamp":1791405484903,"version":"4.3.3"},"reference-count":61,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T00:00:00Z","timestamp":1669680000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: After liver transplantation (LT), long-term immunosuppression (IS) is essential. IS is associated with de novo malignancies, and the incidence of colorectal cancer (CRC) is increased in LT patients. We assessed course of disease in patients with de novo CRC after LT with focus of IS and impact on survival in a retrospective, single-center study. Materials and\u00a0Methods: All patients diagnosed with CRC after LT between 1988 and 2019 were included. The management of IS regimen following diagnosis and the oncological treatment approach were analyzed: Kaplan\u2013Meier analysis as well as univariate and multivariate analysis were performed. Results: A total of 33 out of 2744 patients were diagnosed with CRC after LT. Two groups were identified: patients with restrictive IS management undergoing dose reduction (RIM group, n = 20) and those with unaltered regimen (maintenance group, n = 13). The groups did not differ in clinical and oncological characteristics. Statistically significant improved survival was found in Kaplan\u2013Meier analysis for patients in the RIM group with 83.46 (8.4\u2013193.1) months in RIM and 24.8 (0.5\u2013298.9) months in the maintenance group (log rank = 0.02) and showed a trend in multivariate cox regression (p = 0.054, HR = 14.3, CI = 0.96\u2013213.67). Conclusions: Immunosuppressive therapy should be reduced further in patients suffering from CRC after LT in an individualized manner to enable optimal oncological therapy and enable improved survival.<\/jats:p>","DOI":"10.3390\/medicina58121755","type":"journal-article","created":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T02:21:57Z","timestamp":1669774917000},"page":"1755","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A Reduction of Calcineurin Inhibitors May Improve Survival in Patients with De Novo Colorectal Cancer after Liver Transplantation"],"prefix":"10.3390","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8294-3560","authenticated-orcid":false,"given":"Ramin Raul","family":"Ossami Saidy","sequence":"first","affiliation":[{"name":"Department of Surgery, Campus Charit\u00e9 Mitte | Campus Virchow Klinikum, Charit\u00e9-Universit\u00e4tsmedizin Berlin, Charit\u00e9 University Medicine Berlin, 13353 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Wegener","sequence":"additional","affiliation":[{"name":"Department of Surgery, Campus Charit\u00e9 Mitte | Campus Virchow Klinikum, Charit\u00e9-Universit\u00e4tsmedizin Berlin, Charit\u00e9 University Medicine Berlin, 13353 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6395-0845","authenticated-orcid":false,"given":"Deniz","family":"Uluk","sequence":"additional","affiliation":[{"name":"Department of Surgery, Campus Charit\u00e9 Mitte | Campus Virchow Klinikum, Charit\u00e9-Universit\u00e4tsmedizin Berlin, Charit\u00e9 University Medicine Berlin, 13353 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Dittrich","sequence":"additional","affiliation":[{"name":"Department of Surgery, Campus Charit\u00e9 Mitte | Campus Virchow Klinikum, Charit\u00e9-Universit\u00e4tsmedizin Berlin, Charit\u00e9 University Medicine Berlin, 13353 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzel","family":"Sch\u00f6ning","sequence":"additional","affiliation":[{"name":"Department of Surgery, Campus Charit\u00e9 Mitte | Campus Virchow Klinikum, Charit\u00e9-Universit\u00e4tsmedizin Berlin, Charit\u00e9 University Medicine Berlin, 13353 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9674-0756","authenticated-orcid":false,"given":"Georg","family":"Lurje","sequence":"additional","affiliation":[{"name":"Department of Surgery, Campus Charit\u00e9 Mitte | Campus Virchow Klinikum, Charit\u00e9-Universit\u00e4tsmedizin Berlin, Charit\u00e9 University Medicine Berlin, 13353 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4499-1673","authenticated-orcid":false,"given":"Robert","family":"\u00d6llinger","sequence":"additional","affiliation":[{"name":"Department of Surgery, Campus Charit\u00e9 Mitte | Campus Virchow Klinikum, Charit\u00e9-Universit\u00e4tsmedizin Berlin, Charit\u00e9 University Medicine Berlin, 13353 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik Paul","family":"Modest","sequence":"additional","affiliation":[{"name":"Department of Hematology, Oncology and Cancer Immunology, Campus Charit\u00e9 Mitte | Campus Virchow Klinikum, Charit\u00e9-Universit\u00e4tsmedizin Berlin, Charit\u00e9 University Medicine Berlin, 13353 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6206-0226","authenticated-orcid":false,"given":"Frank","family":"Tacke","sequence":"additional","affiliation":[{"name":"Department of Hepatology and Gastroenterology, Campus Charit\u00e9 Mitte | Campus Virchow Klinikum, Charit\u00e9-Universit\u00e4tsmedizin Berlin, Charit\u00e9 University Medicine Berlin, 13353 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3220-6236","authenticated-orcid":false,"given":"Oliver","family":"Haase","sequence":"additional","affiliation":[{"name":"Department of Surgery, Campus Charit\u00e9 Mitte | Campus Virchow Klinikum, Charit\u00e9-Universit\u00e4tsmedizin Berlin, Charit\u00e9 University Medicine Berlin, 13353 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann","family":"Pratschke","sequence":"additional","affiliation":[{"name":"Department of Surgery, Campus Charit\u00e9 Mitte | Campus Virchow Klinikum, Charit\u00e9-Universit\u00e4tsmedizin Berlin, Charit\u00e9 University Medicine Berlin, 13353 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Eurich","sequence":"additional","affiliation":[{"name":"Department of Surgery, Campus Charit\u00e9 Mitte | Campus Virchow Klinikum, Charit\u00e9-Universit\u00e4tsmedizin Berlin, Charit\u00e9 University Medicine Berlin, 13353 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,11,29]]},"reference":[{"key":"ref_1","first-page":"101681","article-title":"Immunosuppression in liver transplant","volume":"46\u201347","author":"Little","year":"2020","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/TP.0000000000000965","article-title":"Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial","volume":"100","author":"Geissler","year":"2016","journal-title":"Transplantation"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"845438","DOI":"10.1155\/2014\/845438","article-title":"The Role of mTOR Inhibitors in Liver Transplantation: Reviewing the Evidence","volume":"2014","author":"Klintmalm","year":"2014","journal-title":"J. Transplant."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1111\/j.1600-6143.2010.03181.x","article-title":"Comparison of the incidence of malignancy in recipients of different types of organ: A UK Registry audit","volume":"10","author":"Collett","year":"2010","journal-title":"Am. J. Transplant."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1001\/jama.2011.1592","article-title":"Spectrum of cancer risk among US solid organ transplant recipients","volume":"306","author":"Engels","year":"2011","journal-title":"JAMA"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1002\/lt.23531","article-title":"Burden of de novo malignancy in the liver transplant recipient","volume":"18","author":"Chandok","year":"2012","journal-title":"Liver Transpl."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.anclin.2017.04.002","article-title":"Infectious Complications and Malignancies Arising After Liver Transplantation","volume":"35","author":"Idossa","year":"2017","journal-title":"Anesthesiol. Clin."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e12906","DOI":"10.1111\/ctr.12906","article-title":"Why do patients die after a liver transplantation?","volume":"31","author":"Daniel","year":"2017","journal-title":"Clin. Transplant."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"8753","DOI":"10.3748\/wjg.v21.i29.8753","article-title":"Neoplastic disease after liver transplantation: Focus on de novo neoplasms","volume":"21","author":"Burra","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"M\u00e1rmol, I., S\u00e1nchez-de-Diego, C., Pradilla Dieste, A., Cerrada, E., and Rodriguez Yoldi, M.J. (2017). Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18010197"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1007\/s00268-021-06219-9","article-title":"Characteristics and Prognosis of Colorectal Cancer after Liver or Kidney Transplantation","volume":"45","author":"Kim","year":"2021","journal-title":"World J. Surg."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/j.1600-6143.2010.03049.x","article-title":"Risk of colorectal carcinoma in post-liver transplant patients: A systematic review and meta-analysis","volume":"10","author":"Nicolaas","year":"2010","journal-title":"Am. J. Transplant."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/liv.13947","article-title":"Incidence and outcome of colorectal cancer in liver transplant recipients: A national, multicentre analysis on 8115 patients","volume":"39","author":"Rompianesi","year":"2019","journal-title":"Liver Int."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1002\/lt.23741","article-title":"Incidence of colorectal cancer after liver transplantation for primary sclerosing cholangitis: A systematic review and meta-analysis","volume":"19","author":"Singh","year":"2013","journal-title":"Liver Transpl."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1002\/hep.31731","article-title":"De Novo Colorectal and Pancreatic Cancer in Liver-Transplant Recipients: Identifying the Higher-Risk Populations","volume":"74","author":"Mara","year":"2021","journal-title":"Hepatology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"5796108","DOI":"10.1155\/2019\/5796108","article-title":"Colorectal Cancer Characteristics and Outcomes after Solid Organ Transplantation","volume":"2019","author":"Merchea","year":"2019","journal-title":"J. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1097\/TP.0000000000003998","article-title":"De Novo Malignancy After Liver Transplantation: Risk Assessment, Prevention, and Management-Guidelines From the ILTS-SETH Consensus Conference","volume":"106","author":"Colmenero","year":"2022","journal-title":"Transplantation"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1080\/17474124.2020.1797483","article-title":"Medical care of liver transplant patients","volume":"14","author":"Hoppmann","year":"2020","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Ossami Saidy, R.R., Postel, M.P., Pfl\u00fcger, M.J., Schoening, W., \u00d6llinger, R., G\u00fcl-Klein, S., Schmelzle, M., Tacke, F., Pratschke, J., and Eurich, D. (2021). Minimization of Immunosuppressive Therapy Is Associated with Improved Survival of Liver Transplant Patients with Recurrent Hepatocellular Carcinoma. Cancers, 13.","DOI":"10.3390\/cancers13071617"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Pesthy, S., Wegener, E., Ossami Saidy, R.R., Timmermann, L., Uluk, D., Aydin, M., Dziodzio, T., Schoening, W., Lurje, G., and \u00d6llinger, R. (2022). Reducing Immunosuppression in Patients with De Novo Lung Carcinoma after Liver Transplantation Could Significantly Prolong Survival. Cancers, 14.","DOI":"10.3390\/cancers14112748"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S1470-2045(07)70185-7","article-title":"Current TNM staging of colorectal cancer","volume":"8","author":"Greene","year":"2007","journal-title":"Lancet Oncol."},{"key":"ref_22","unstructured":"James, D., and Brierley, M.K.G. (2016). Christian Wittekind. TNM Classification of Malignant Tumours, Wiley and the UICC. [8th ed.]."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"458","DOI":"10.14309\/ajg.0000000000001122","article-title":"ACG Clinical Guidelines: Colorectal Cancer Screening 2021","volume":"116","author":"Shaukat","year":"2021","journal-title":"Off. J. Am. Coll. Gastroenterol. ACG"},{"key":"ref_24","unstructured":"(2022, October 20). Available online: https:\/\/register.awmf.org\/de\/leitlinien\/detail\/021-007OL."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1111\/j.1523-1755.2005.00602.x","article-title":"BK virus nephritis: Risk factors, timing, and outcome in renal transplant recipients","volume":"68","author":"Vasudev","year":"2005","journal-title":"Kidney Int."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1111\/ajt.17021","article-title":"Cumulative exposure to tacrolimus and incidence of cancer after liver transplantation","volume":"22","author":"Colmenero","year":"2022","journal-title":"Am. J. Transplant."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/liv.13651","article-title":"How to improve long-term outcome after liver transplantation?","volume":"38","author":"Durand","year":"2018","journal-title":"Liver Int."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/SLA.0000000000002650","article-title":"No Gains in Long-term Survival After Liver Transplantation Over the Past Three Decades","volume":"269","author":"Rana","year":"2019","journal-title":"Ann. Surg."},{"key":"ref_29","first-page":"89","article-title":"Epidemiology of colorectal cancer: Incidence, mortality, survival, and risk factors","volume":"14","author":"Rawla","year":"2019","journal-title":"Prz. Gastroenterol."},{"key":"ref_30","unstructured":"ZfKD (2019). Zentrum f\u00fcr Krebsregisterdaten (ZfKD) im Robert Koch-Institut (2019): Datensatz des ZfKD auf Basis der Epidemiologischen LandesKrebsRegisterDaten, Verf\u00fcgbare Diagnosejahre bis 2016, ZfKD. Version: Epi2018_1."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"101514","DOI":"10.1016\/j.clinre.2020.07.019","article-title":"Risk factors of de novo malignancies after liver transplantation: A French national study on 11004 adult patients","volume":"45","author":"Altieri","year":"2021","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"71","DOI":"10.4251\/wjgo.v4.i4.71","article-title":"An overview of colorectal cancer survival rates and prognosis in Asia","volume":"4","author":"Safaee","year":"2012","journal-title":"World J. Gastrointest. Oncol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1097\/SLA.0b013e3182369101","article-title":"Prediction of Prognosis Is Not Improved by the Seventh and Latest Edition of the TNM Classification for Colorectal Cancer in a Single-Center Collective","volume":"254","author":"Nitsche","year":"2011","journal-title":"Ann. Surg."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.5858\/2008-132-1600-CCSIIP","article-title":"Colorectal carcinoma: Selected issues in pathologic examination and staging and determination of prognostic factors","volume":"132","author":"Washington","year":"2008","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/S0140-6736(13)61649-9","article-title":"Colorectal cancer","volume":"383","author":"Brenner","year":"2014","journal-title":"Lancet"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1200\/JCO.2009.24.0952","article-title":"Revised TN categorization for colon cancer based on national survival outcomes data","volume":"28","author":"Gunderson","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3390\/gastroent12030025","article-title":"Foremost Concepts in Mechanisms of De Novo Post-Liver Transplantation Malignancy","volume":"12","author":"Peruhova","year":"2021","journal-title":"Gastroenterol. Insights"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.3389\/fimmu.2020.01052","article-title":"Colorectal Cancer Immune Infiltrates: Significance in Patient Prognosis and Immunotherapeutic Efficacy","volume":"11","author":"Guo","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ejca.2020.08.024","article-title":"Immune scores in colorectal cancer: Where are we?","volume":"140","author":"Malka","year":"2020","journal-title":"European J. Cancer"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"577125","DOI":"10.3389\/fcell.2020.577125","article-title":"Development of a Metastasis-Related Immune Prognostic Model of Metastatic Colorectal Cancer and Its Usefulness to Immunotherapy","volume":"8","author":"Luo","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1111\/ajt.15205","article-title":"Outcomes of immunosuppression minimization and withdrawal early after liver transplantation","volume":"19","author":"Shaked","year":"2019","journal-title":"Am. J. Transplant."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1016\/j.transproceed.2005.03.070","article-title":"Long-term outcome of immunosuppression withdrawal after liver transplantation","volume":"37","author":"Girlanda","year":"2005","journal-title":"Transplant Proc."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1097\/MEG.0000000000001435","article-title":"Immunosuppressive drug withdrawal late after liver transplantation improves the lipid profile and reduces infections","volume":"31","author":"Duizendstra","year":"2019","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Toti, L., Manzia, T.M., Blasi, F., and Tisone, G. (2021). Withdrawal of Immunosuppression after Liver Transplantation. Liver Transplantation, Wiley.","DOI":"10.1002\/9781119634010.ch42"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1101\/gad.314617.118","article-title":"Roles of the immune system in cancer: From tumor initiation to metastatic progression","volume":"32","author":"Gonzalez","year":"2018","journal-title":"Genes Dev."},{"key":"ref_46","unstructured":"Rezaei, N. (2020). Cancer Immunoediting: Immunosurveillance, Immune Equilibrium, and Immune Escape. Cancer Immunology: A Translational Medicine Context, Springer International Publishing."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3390\/transplantology2040042","article-title":"Strategies to Improve Immune Suppression Post-Liver Transplantation: A Review","volume":"2","author":"Mohamed","year":"2021","journal-title":"Transplantology"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.jhep.2013.04.003","article-title":"Immunosuppression minimization vs. complete drug withdrawal in liver transplantation","volume":"59","author":"Rimola","year":"2013","journal-title":"J. Hepatol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1007\/s12072-020-10091-5","article-title":"Immunosuppressive regimens for adult liver transplant recipients in real-life practice: Consensus recommendations from an Italian Working Group","volume":"14","author":"Cillo","year":"2020","journal-title":"Hepatol. Int."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1111\/tri.13897","article-title":"High trough levels of everolimus combined to sorafenib improve patients survival after hepatocellular carcinoma recurrence in liver transplant recipients","volume":"34","author":"Nitta","year":"2021","journal-title":"Transpl. Int."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13578-020-00396-1","article-title":"mTOR signaling pathway and mTOR inhibitors in cancer: Progress and challenges","volume":"10","author":"Zou","year":"2020","journal-title":"Cell Biosci."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.transproceed.2015.12.071","article-title":"Malignancy After Heart Transplantation Under Everolimus Versus Mycophenolate Mofetil Immunosuppression","volume":"48","author":"Wang","year":"2016","journal-title":"Transplant. Proc."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3892\/br.2020.1376","article-title":"Sirolimus and MMF are insufficient immunosuppressants for regulation of the proliferation of CD133+EpCAM+ cell populations in HCC cell lines","volume":"13","author":"Kim","year":"2020","journal-title":"Biomed. Rep."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1097\/TP.0000000000000555","article-title":"Three-year Outcomes in De Novo Liver Transplant Patients Receiving Everolimus With Reduced Tacrolimus: Follow-Up Results From a Randomized, Multicenter Study","volume":"99","author":"Fischer","year":"2015","journal-title":"Transplantation"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s12072-013-9492-6","article-title":"Everolimus-based immunosuppression in liver transplant recipients: A single-centre experience","volume":"8","author":"Cholongitas","year":"2014","journal-title":"Hepatol. Int."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Navarro-Villar\u00e1n, E., Tinoco, J., Jim\u00e9nez, G., Pereira, S., Wang, J., Aliseda, S., Rodr\u00edguez-Hern\u00e1ndez, M.A., Gonz\u00e1lez, R., Mar\u00edn-G\u00f3mez, L.M., and G\u00f3mez-Bravo, M.A. (2016). Differential Antitumoral Properties and Renal-Associated Tissue Damage Induced by Tacrolimus and Mammalian Target of Rapamycin Inhibitors in Hepatocarcinoma: In Vitro and In Vivo Studies. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0160979"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41392-020-0116-z","article-title":"Comprehensive review of targeted therapy for colorectal cancer","volume":"5","author":"Xie","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.3389\/fimmu.2020.01624","article-title":"Colorectal Cancer Immunotherapy: Options and Strategies","volume":"11","author":"Johdi","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"e194489","DOI":"10.1001\/jamaoncol.2019.4489","article-title":"The Role of Maintenance Strategies in Metastatic Colorectal Cancer: A Systematic Review and Network Meta-analysis of Randomized Clinical Trials","volume":"6","author":"Sonbol","year":"2020","journal-title":"JAMA Oncol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/ags3.12227","article-title":"Multidisciplinary approach of liver metastases from colorectal cancer","volume":"3","author":"Adam","year":"2019","journal-title":"Ann. Gastroenterol. Surg."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.21037\/atm-20-4416","article-title":"Liver resection is beneficial for patients with colorectal liver metastases and extrahepatic disease","volume":"8","author":"Lang","year":"2020","journal-title":"Ann. Transl. Med."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/58\/12\/1755\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:29:51Z","timestamp":1760146191000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/58\/12\/1755"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,29]]},"references-count":61,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["medicina58121755"],"URL":"https:\/\/doi.org\/10.3390\/medicina58121755","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,29]]}}}